Annual Current Ratio
3.80
-1.15-23.23%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual current ratio is 3.80, with the most recent change of -1.15 (-23.23%) on December 31, 2023.
- During the last 3 years, RVNC annual current ratio has fallen by -3.58 (-48.51%).
- RVNC annual current ratio is now -81.99% below its all-time high of 21.10, reached on December 31, 2015.
Performance
RVNC Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
4.12
+0.38+10.16%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly current ratio is 4.12, with the most recent change of +0.38 (+10.16%) on September 30, 2024.
- Over the past year, RVNC quarterly current ratio has dropped by -0.61 (-12.90%).
- RVNC quarterly current ratio is now -82.99% below its all-time high of 24.22, reached on March 31, 2015.
Performance
RVNC Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
RVNC Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.2% | -12.9% |
| 3 y3 years | -48.5% | -7.6% |
| 5 y5 years | -41.5% | -36.2% |
RVNC Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.2% | +3.8% | -25.9% | +21.9% |
| 5 y | 5-year | -48.5% | +3.8% | -66.9% | +21.9% |
| alltime | all time | -82.0% | +7500.0% | -83.0% | +8140.0% |
Revance Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 4.12(+10.2%) |
| Jun 2024 | - | 3.74(-30.4%) |
| Mar 2024 | - | 5.37(+41.3%) |
| Dec 2023 | 3.80(-23.2%) | 3.80(-19.7%) |
| Sep 2023 | - | 4.73(-7.6%) |
| Jun 2023 | - | 5.12(+23.7%) |
| Mar 2023 | - | 4.14(-16.4%) |
| Dec 2022 | 4.95(+35.2%) | 4.95(-11.0%) |
| Sep 2022 | - | 5.56(+64.5%) |
| Jun 2022 | - | 3.38(-15.9%) |
| Mar 2022 | - | 4.02(+9.8%) |
| Dec 2021 | 3.66(-50.4%) | 3.66(-17.9%) |
| Sep 2021 | - | 4.46(-26.8%) |
| Jun 2021 | - | 6.09(-23.8%) |
| Mar 2021 | - | 7.99(+8.3%) |
| Dec 2020 | 7.38(+1.9%) | 7.38(+4.4%) |
| Sep 2020 | - | 7.07(-32.5%) |
| Jun 2020 | - | 10.48(-15.8%) |
| Mar 2020 | - | 12.45(+72.0%) |
| Dec 2019 | 7.24(+11.4%) | 7.24(+12.1%) |
| Sep 2019 | - | 6.46(+15.6%) |
| Jun 2019 | - | 5.59(-31.2%) |
| Mar 2019 | - | 8.13(+25.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | 6.50(-52.4%) | 6.50(-4.3%) |
| Sep 2018 | - | 6.79(-20.9%) |
| Jun 2018 | - | 8.58(-27.8%) |
| Mar 2018 | - | 11.89(-12.9%) |
| Dec 2017 | 13.65(+39.1%) | 13.65(+87.5%) |
| Sep 2017 | - | 7.28(-8.2%) |
| Jun 2017 | - | 7.93(-3.4%) |
| Mar 2017 | - | 8.21(-16.3%) |
| Dec 2016 | 9.81(-53.5%) | 9.81(-17.6%) |
| Sep 2016 | - | 11.91(-35.1%) |
| Jun 2016 | - | 18.34(-4.0%) |
| Mar 2016 | - | 19.10(-9.5%) |
| Dec 2015 | 21.10(+25.1%) | 21.10(+72.7%) |
| Sep 2015 | - | 12.22(-9.5%) |
| Jun 2015 | - | 13.51(-44.2%) |
| Mar 2015 | - | 24.22(+43.6%) |
| Dec 2014 | 16.87(>+9900.0%) | 16.87(+30.3%) |
| Sep 2014 | - | 12.95(+17.6%) |
| Jun 2014 | - | 11.01(+173.2%) |
| Mar 2014 | - | 4.03(+3930.0%) |
| Dec 2013 | 0.10(+100.0%) | 0.10(0.0%) |
| Sep 2013 | - | 0.10(+100.0%) |
| Dec 2012 | 0.05(-98.5%) | 0.05 |
| Dec 2011 | 3.40 | - |
FAQ
- What is Revance Therapeutics annual current ratio?
- What is the all time high annual current ratio for Revance Therapeutics?
- What is Revance Therapeutics annual current ratio year-on-year change?
- What is Revance Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Revance Therapeutics?
- What is Revance Therapeutics quarterly current ratio year-on-year change?
What is Revance Therapeutics annual current ratio?
The current annual current ratio of RVNC is 3.80
What is the all time high annual current ratio for Revance Therapeutics?
Revance Therapeutics all-time high annual current ratio is 21.10
What is Revance Therapeutics annual current ratio year-on-year change?
Over the past year, RVNC annual current ratio has changed by -1.15 (-23.23%)
What is Revance Therapeutics quarterly current ratio?
The current quarterly current ratio of RVNC is 4.12
What is the all time high quarterly current ratio for Revance Therapeutics?
Revance Therapeutics all-time high quarterly current ratio is 24.22
What is Revance Therapeutics quarterly current ratio year-on-year change?
Over the past year, RVNC quarterly current ratio has changed by -0.61 (-12.90%)